chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Approximately 1320 hrs, I gave child DTaP #5, IPV # 4, and MMR #2. Child was sitting in a chair on my left. I gave child's mom a PPD plant and picked up a syringe for another IMMI. Child fell forward onto the floor, face first. Mom and I picked her up and she was conscious but extremely pale. I called for assistance and placed a cold pack on the back of her neck. Pulse 64, resp. 20. I moved child (carried) to an exam room and laid her on the exam table with a cold pack under her neck. Nursing supervisor assisted. Child's pulse 72, resp. 20. Child was slightly diaphoretic, cold cloth applied to face and forehead. Mom became "faint" and pale in color. I talked to mom and had her take deep breaths while child sipped juice and ate crackers. Child's color returned, pulse 84, resp 20. I stayed with child about 15 min and deferred mom's other vaccination. Child stayed in room until 1410 hrs and was walked to the front desk for checkout. Injection sites showed no redness or swelling. No bruising noted on child's face or arms. At 1942 hrs., I called mom and she said the child played normally today and was tired this evening but had no other signs/symptoms.
Walking back to car moving arm left arm went numb, then left hip, then left leg. (Day of dose 1) Over the course of the last month SOB, occasional dizziness, one fall with weakness, mild aphasia and elevated blood pressures October 4 also both doses mild feelings of aggression days post injection up to 10 days
very bad sore throat; stuffy head; minoe loose cough; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of OROPHARYNGEAL PAIN (very bad sore throat), HEAD DISCOMFORT (stuffy head) and COUGH (minoe loose cough) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Apr-2021, the patient experienced OROPHARYNGEAL PAIN (very bad sore throat), HEAD DISCOMFORT (stuffy head) and COUGH (minoe loose cough). At the time of the report, OROPHARYNGEAL PAIN (very bad sore throat), HEAD DISCOMFORT (stuffy head) and COUGH (minoe loose cough) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient reported having done self treatment with Dayquil, Chloraseptic spray and rubbing on Vicks at night.  Patient reported doctor's prescribed medicines as 'an antibiotics shot and some other medicines'. No concomitant medicines information provided.
I had extreme fatigue and general malaise, joint pain, I just felt terrible, my head felt as if it was too heavy for my neck to hold it up. I was supposed to be travelling so I chose to take a home COVID-19 test to make sure that I was not sick before I left home. The first test I used was expired but did come back positive. I did go out and get a second test that also came back positive. I called my doctor, we discussed the pro's and con's of taking PAXLOVID, I choose not to take it and in five days I was feeling better. For three full weeks I did experience not having headaches which I have not had since getting the idiopathic intercranial hypertension.
Experience mild adverse reaction; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Experience mild adverse reaction) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Previously administered products included for Prophylactic vaccination: Janssen covid-19 VACCINE in February 2021 and Janssen covid-19 VACCINE (Patient reported that J AND J vaccine had knocked her out) in February 2021. Past adverse reactions to the above products included Fever with Janssen covid-19 VACCINE; and Teeth chattering with Janssen covid-19 VACCINE.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Experience mild adverse reaction). At the time of the report, VACCINATION COMPLICATION (Experience mild adverse reaction) had resolved.            No Concomitant medications were reported. No treatment medications were reported.  Patient reported that J AND J vaccine had knocked her out. After taking Moderna on an unspecified date patient experienced mild adverse reaction patient also reported that she felt milder and it was like nothing within 48 hours she felt completely normal. Outcome of full blown fever and teeth chattering was not reported.
17 year old patient was given Moderna and is underage (4/15/21).  Second shot administered per CDC guidelines 5/6/21.  No reported ill effects.
Seizure-like episodes - absent seizure followed by severe headache, confusion, excessive salivation, heart rate drop to 36 BPM, cold sweat, instability, extreme fatigue. 3 total episodes in 24 hours. Patient was taken to the ER where he received bloodwork, urine test, and a CT scan. Discharged with a referral to neurology.
pt recv vax;devel local swelling & erythema at inject site;devel allergic rxn characterized by swelling of lips,shaking,hives on neck & head,and tachycardia;tx w/ dph & IV solu medrol;
Vasovagal syncope (fainting) approximately 20 hours after vaccine. Received vaccine at 12:40pm, no issues other than sore arm that day.  The next morning woke at 7:30 and got up for a few minutes with a very sore arm.  Went back to bed until about 8:30.  After waking at 8:30, walked into the hallway and felt like passing out.  Sat down and then layed on the floor hoping to relieve the symptoms, but within a few minutes lost consciousness and convulsed for about 30 seconds (according to husband). Returned to bed and rested the rest of the day.
This case was reported by a consumer via call center representative and described the occurrence of headache in a 64-year-old female patient who received SHINGRIX for prophylaxis. On 14th September 2018, the patient received the 1st dose of SHINGRIX. On 14th September 2018, 8 hrs after receiving SHINGRIX, the patient experienced headache, nausea, tingling of extremity, fatigue and fever. On 20th September 2018, the patient experienced elevated sedimentation rate. On an unknown date, the outcome of the headache, nausea, tingling of extremity, fatigue and fever were recovered/resolved and the outcome of the elevated sedimentation rate was unknown. It was unknown if the reporter considered the headache, nausea, tingling of extremity, fatigue, fever and elevated sedimentation rate to be related to SHINGRIX. Additional details were provided as follows: The patient reported that, after receiving SHINGRIX, she experienced headache, fatigue, nausea, fever, tingling in both hands and fingers and after day 3, an intermittent fever that would come and go. The patient saw her physician who did a sedimentation rate, and found that it was 40 mm per hr. On 5th October 2018, a repeat test was done, but results were not yet know. At time of report, all other events had resolved. The physician's contact details were provided.
2 days after receiving the 2nd booster I was exposed in my home to Covid-19 by a person who was asymptomatic at the time (5/14).  That person tested positive for Covid-19 on 5/15 and notified me.  On 5/18 I woke with a sore throat, drainage, and headache.  I tested for Covid-19 using an at-home rapid antigen test which was positive.  Over the next 5 days I experienced fever up to 101.6, headache, sore throat, drainage, and cough.  I started to improve on the 5th day.  Today is the 8th day and I feel almost back to fine.  Still have occasional productive cough with  no other symptoms.  I do not think I had an adverse reaction to the booster.
12AUG95 6PM pt had itching (legs, neck); 13AUG95 9PM pt exp hives all over body; 14AUG95 pt still exp mild itching & hives & a h/a but no temp; pvt MD recommended DPH, not to complete Hep B series
pfizer Covid Vaccine (5-11 years) orange top expiration date was -7/31/2022 and was given 08/02/2022.
pt recv vax 12MAY97 & returned to clinic 14MAY97 for PPD & reported pain-noc sweats, rash, insomnia-did not go to work secondary to sxs;
Information has been received from a physician concerning an 8 year old female who on 07-AUG-2007 was vaccinated with a dose of varicella virus vaccine live (Oka/Merck) (lot# 658197/0853U). On 09-AUG-2007, the patient developed localized rash at the injection site. Unspecified medical attention was sought. Subsequently, the patient recovered. There was no product quality complaint. Additional information has been requested.
really knocked down by the vaccine; feeling weakening in her muscles; This is a spontaneous report received from contactable reporters (Consumer). The reporter is the parent. A 22-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), administration date 23Feb2021 (Lot number: EN6202) as dose 1, single and administration date 16Mar2021 (Lot number: EN6207) as dose 2, single; both at the age of 21 years for COVID-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: MALAISE (medically significant) with onset 2021, outcome "unknown", described as "really knocked down by the vaccine"; MUSCULAR WEAKNESS (medically significant) with onset 2021, outcome "unknown", described as "feeling weakening in her muscles". Clinical course details: The patient reported that when she got the booster dose, she started feeling weakening in her muscles and maybe was really knocked down by the vaccine which it was also how she felt after the first and second doses of the Pfizer COVID vaccine.
A non-serious spontaneous report of administration of expired product was received from a physician concerning a nine-year-old patient. Neither the patient's past medical history nor the concomitant medications were reported. The product expired on 02-Dec-2010. The patient received expired FLUMIST on 04-Dec-2010. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments are not applicable, and the event was considered resolved.
Pt started on 2/6 with sx of cough/congestion/no taste or smell. Pt denied fever but does has asthma and at times a little sob but at time of call was okay and this is not a new sx for pt. Pt received 1st vaccine dose on 2/4.
patient called to pharmacy 8/25/2023 1:57p and states that with her first dose she didn't have any issues other than a sore arm. she states with this dose she has a 3 to 4 inch bright red spot around the injection site, it is painful, hot, and itches.  i referred her to her dr since it was hot. i spoke with patient 8/25/2023 4:05p and she states that her provider's nurse  states that it is a normal reaction and for her to try benadryl, and ice packs and to draw a circle around the area to see if it grows or decreases in size.
approximately 1.5 hrs after my vaccine I started to feel lightheaded and flushed all over my body.  My heart rate was 120's and my temperature was 100.2F. No difficulty breathing, SOB, chest pain or rash.   I was checked into the clinic and monitored in the Nurse Treatment Center.  I was placed on a bedside cardiac monitor, an EKG was done,  labs drawn and IV fluids administered. I was there for approx 1 hr and discharged to home.  Temp was 99.1 HR 100's.
fever; injection site swelling; Injection site pain; chills; feeling unwell; fast heartbeat; weakness; muscle and body ache; muscle and body ache; headache; tiredness; nausea; This is a spontaneous report from a contactable consumer (patient) reported for herself. A 67-years-old female patient (patient was not pregnant at the time of vaccination) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: unknown, Expiration date: unknown) via an unspecified route of administration, administered in left arm on 25Feb2021 at 00:00 am (age at vaccination was 67 years) as dose 1, single for COVID-19 immunization. The patient's medical history included diabetes and high blood pressure from an unknown date. The patient did not have any known allergies. Concomitant medications the patient received within 2 weeks of vaccination included metformin, atorvastatin, glyburide and lisinopril all taken for an unspecified indication. The facility where the most recent COVID-19 vaccine was administered was Hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 26Feb2021 at 01:00 am, the patient experienced fever, injection site swelling/pain, chills, feeling unwell, fast heartbeat, weakness, chills, muscle and body ache, headache, tiredness and some nausea. The patient took acetaminophen extra strength. The patient recovered with lasting effects. The outcome of the events was resolved with sequel on an unspecified date in 2021.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Tiredness Body ache Headache Fever Chills Slight cough Took ibuprofen May 12 8am, 3pm, 9pm. May 13 8am. Took Morton May 13 3pm. Symptoms improve until medicine wears off.
Terrible headaches it continued into the following weeks; This is a spontaneous report from a non-contactable consumer (reporting for herself).   A 70-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection, Batch/Lot number: unable to locate or read the details), via an unspecified route of administration on an unspecified date (at the age of 70-year-old) as UNKNOWN, SINGLE DOSE for covid-19 immunization. The patient medical history and concomitant medications were not reported. Prior to vaccination, the patient was unknown with diagnosed of COVID-19; Since the vaccination, the patient not been tested for COVID-19. The patient reported that terrible headaches it continued into the following weeks on 23Feb2021. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Information has been received from an office nurse concerning a patient who was vaccinated with Pneumococcal 23v polysaccharide vaccine (649695/0512P). Subsequently the patient experienced injection site tenderness, injection site redness and also fluid collection which progressed down arm. Subsequently, the patient recovered from injection site tenderness, injection site redness and fluid collection which progressed down arm. Injection site tenderness, injection site redness and fluid collection which progressed down arm were considered other important medical events (OMIC). Additional information has been requested.
Peristent induration and erythema at the vaccine site 3 week after vaccination. improved without intervention.
This spontaneous report was received from a certified medical assistant and refers to a patient of unknown age and gender. There was no information regarding their medical history, concurrent conditions nor concomitant therapies provided. On 29-OCT-2021, the patient was vaccinated with an improperly stored dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) orally, lot # 1741275, expiration date 07-MAR-2022 (exact dose was not provided) for prophylaxis (product storage error). The administered vaccine was stored in a temperature of 34.8 degree Fahrenheit (F) for 192 hours. No previous temperature excursion occurred. No adverse effect was reported. This is one of several reports from the same reporter.; Sender's Comments: US-009507513-2112USA000785: US-009507513-2112USA000788: US-009507513-2112USA000790: US-009507513-2112USA000789: US-009507513-2112USA000791: US-009507513-2112USA000789: US-009507513-2112USA000792.
Pontine stroke causing dysarthria, right facial droop, right arm weakness, and unsteady gait.
Area where vaccine given is painful, red, swollen. Pt also c/o cough & congestion since vaccine admin. (left arm).
Sore upper arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore upper arm) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036B21A) for COVID-19 vaccination.     Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication and Medications for high cholesterol (didn't specify)    On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, the patient experienced PAIN IN EXTREMITY (Sore upper arm). On 16-Apr-2021, PAIN IN EXTREMITY (Sore upper arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Itching, swelling, redness and warmth at injection site on upper left arm 8 days after shot.  Applied ice and Hydrocortisone 1% Cream
This spontaneous report as received from a pharmacist refers to a 61 years old female patient with no pertinent medical history and no drug reactions or allergies. The reporter stated that she held a ZOSTAVAX clinic, on 02-MAY-2014, patient was administered with ZOSTAVAX lot number K000456, expiration date-15-DEC-2014, dose single dose, route SQ. On an unknown date in May 2014, patient the patient developed redness, swelling and induration at injection site. The pharmacist stated she became aware of the adverse events the patient was experiencing on the weekend (03-MAY-2014 and 04-MAY-2014). The vaccine clinic took place at a high school. Vaccine recipient was teacher. The pharmacist spoke to the school nurse on Monday 05-MAY-2014. The school nurse shared with the pharmacist that the adverse experiences, the teacher was experiencing, was resolving. There was no hospitalization. No specific treatments mentioned. The pharmacist shared the initials, gender and age of each ZOSTAVAX vaccine recipient. All vaccine recipients were women. The pharmacist learned from school nurse that one of the patient experiences of redness spread to over 5 inches from injection site, the pharmacist unable to identify which patient. Patient sought medical attention (called pharmacy). The patient did not receive treatment for the adverse event. There was no Lab diagnosis or studies performed. The outcome of redness, swelling and induration at injection site was recovering. No product quality complaint was involved. This is one of 9 reports from the same source. Additional information has been requested.
Information has been received from a physician and an employee in a physician's office concerning a 69 year old white female with an allergy to aspirin and seasonal allergies who on approximately 10/18/02 was vaccinated with the first dose of pneumococcal vaccine 23 polyvalent (lot 643782/0675M). Concomitant therapy included claritin, Rhinocort and enalapril maleate. Within 48 hrs on 10/18/02, the pt developed a rash and pruritis. Her arm was hot to the touch, she had edema and her arm and elbow were swollen to 4 times their normal site. Subsequently, the physician treated the pt with Benadryl, the rash and pruritis progressed, and the pt visited her physician's office. Upon examination, the pt had an erythematous rash extending above the below the injection site along the fascial planes, a hard indurated lesion at the site of injection, and pain was present on palpation. Subsequently, the pt's arm was only double in size and as of 10/21/02, her arm was still swollen. Indurated lesion, erythematous rash, edema, and pain were considered to be other important medical events by the physician. Addition info is not expected.
Red flushing face, neck chest and arms.  Felt like my face was on fire.  It lasted maybe 30 minutes and then started to go away on my arms, chest and neck.  My face got better, but felt hot for  maybe 2 hrs. after.
I had the 2nd dose and about 10 days give or take i became sick, i had an upper respiratory and was ordered a chest xray , at that time i had moderate Cardiac enlargement. Shortness of breath more than normal
2 hrs after being vaccinated I started feeling chest tightness, shortness of breath, fatigue, and also chest pain along with the tightness. I have been to the ER twice with no solution. I am now being referred to a Cardiologist. It's been 2 weeks now and I am still feeling chest tightness/pain and shortness of breath.
Oblong mark about 2 inches long with 3/4 inch blister in the middle to the left of bellybutton. Oblong mark about 2 inches long to the right of bellybutton. Redness went away within a couple of days. Blister is still healing as of 4-16-2021.
Breakthrough case admission after 4 vaccines Moderna 1/28/21 Lot# 012L20A;  Moderna 2/25/21 Lot# 004M20A;  Moderna 4/21/22 Lot# 048L21A;  Moderna 10/6/22 Lot# 053D22A
Presented for appt on 11/16/12 and received the ZOSTAVAX vaccination. On 11/19/12 patient presented to ER with painful red rash which was diagnosed as shingles. Rash. Acyclovir 800 mg; Other, Acetaminophen/hydrocodone one tab QID.
Information has been received from a physician concerning a 70 year old male with chronic obstructive pulmonary disease, non-small cell lung cancer of the left lung, coronary artery disease and diabetes who in "late January 2008-early February 2008", was vaccinated with Zostavax (Oka/Merck). Concomitant therapy included Metformin, metoprolol, FISH OIL, LASIX and NEUPOGEN. "About 3 weeks ago" the patient developed pancytopenia after the administration of Zostavax (Oka/Merck). The patient's complete blood count in early January was normal. He was hospitalized on 19-FEB-2008 to 23-FEB-2008. On 19-FEB-2008 his complete blood count was the following: white blood cell: 2.3, hemoglobin: 11.1, and platelet count: 41. On 01-MAR-2008 he was admitted to the Intensive Care Unit. On 02-MAR-2008 his complete blood count was the following: white blood cell: 0.7, hemoglobin: 7.2, and platelet count 31,000. On 04-MAR-2008 his platelet count was 7,000. At the time of the report the patient was in the Intensive Care Unit and had not recovered. He was not responding to NEUPOGEN. The physician considered the patient's pancytopenia to be disabling, life threatening, and an other important medical event. Additional information has been requested.
The pt experienced swelling and redness 21 x 17 cm extending to forearm. Treated with Motrin, hydrocortisone with a rapid resolution of symptoms.
Pain in the right arm, cascading up the neck and down to the elbow from the injection site.  Worst post vaccination pain I have ever had, and I have received rabies, anthrax, and yellow fever vaccinations.  Generalized fatigue and malaise from mid day of the injection through the following day.
rashes on both thigh; feel sick (tired; feel sick (tired); This non-serious case was reported by a consumer via interactive digital media and described the occurrence of rash in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On 11-JUN-2023, the patient received the 1st dose of Shingles vaccine. In JUN-2023, less than a week after receiving Shingles vaccine, the patient experienced rash (Verbatim: rashes on both thigh), sickness (Verbatim: feel sick (tired) and tiredness (Verbatim: feel sick (tired)). The outcome of the rash was resolved and the outcome of the sickness and tiredness were not reported.   It was unknown if the reporter considered the rash, sickness and tiredness to be related to Shingles vaccine.     It was unknown if the company considered the rash, sickness and tiredness to be related to Shingles vaccine.   Additional Information: GSK receipt date: 13-Jun-2023 The case was received from the patient via interactive digital media. The patient took a shot last sunday and there was minimal reaction and had rashes on both thigh and felt sick (tired). The patient stated that on the day of reporting, the rashes were subsided. The patient was afraid to take 2nd dose.
Fever for 4 days, throbbing pain in muscles and joints, congestion, loss of appetite, weakness and lethargy.  Fever is gone today.  All other symptoms are still present.